User : SlimVirgin III/sandbox 28
Apter, Alan, et al. (22 March 2006). "Evaluation of Suicidal Thoughts and Behaviors in Children and Adolescents Taking Paroxetine," Journal of Child and Adolescent Psychopharmacology , 16(1–2), pp. 77–90. doi :10.1089/cap.2006.16.77 PMID 16553530 Bass, Alison (2008). Side Effects Doshi, Peter (12 November 2013). "Putting GlaxoSmithKline to the test over paroxetine," BMJ . doi :10.1136/bmj.f6754 PMID 24222673
Food and Drug Administration (19 June 2003). "FDA statement regarding the anti-depressant Paxil for pediatric population" .
Food and Drug Administration (2 May 2007). "Antidepressant Use in Children, Adolescents, and Adults" .
Food and Drug Administration (June 2014). "Medication guide Paxil" .
GlaxoSmithKline (29 January 2007). "Seroxat: Statement from GlaxoSmithKline" , courtesy of BBC News.
Goldacre, Ben (2013). Bad Pharma Hawkins, Zachary (18 August 2001). "To all sales representatives selling Paxil" , Paxil Product Management, GlaxoSmithKline, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Hetrick, Sarah E.; McKenzie, Joanne E.; Cox, Georgina R., et al. (14 November 2012). "Newer generation antidepressants for depressive disorders in children and adolescents," Cochrane Library. doi :10.1002/14651858.CD004851.pub3 PMID 23152227
Jackson, Emily (2012). Law and the Regulation of Medicines , London: Bloomsbury Publishing. Jureidini, Jon (26 December 2002). Jon Jureidini to Mina K. Dulcan , courtesy of Healthy Skepticism.
Jureidini, Jon N.; Tonkin, Ann (May 2003). "Paroxetine in major depression" (letter), Journal of the American Academy of Child and Adolescent Psychiatry , 42(5), p. 514. doi :10.1097/01.CHI.0000046825.95464.DA
Jureidini, Jon N.; McHenry, Leemon B. ; Mansfield, Peter R. "Clinical trials and drug promotion: Selective reporting of study 329" , International Journal of Risk & Safety in Medicine , 20, 2008, pp. 73–81. doi :10.3233/JRS-2008-0426 Jureidini, Jon N.; McHenry, Leemon B. "Conflicted Medical Journals and the Failure of Trust", Accountability in Research 18, 2011, pp. 45-54.
Jureidini, Jon N. "Restoring invisible and abandoned trials: a call for people to publish the findings" (letter), BMJ , 13(346), 13 June 2013. doi :10.1136/bmj.f2865
Jureidini, Jon. Jon Jureidini to Andrew Witty (GSK) , 26 April 2013.
Kagle, Abigail. "Driven to Settle: Eliot Spitzer v. GlaxoSmithKline and Undisclosed Clinical Trials Data Regarding Paxil" , University of Columbia Law School, undated. Keller, Martin B. ; Ryan, Neal D.; Strober, Michael, et al., "Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial" , Journal of the American Academy of Child and Adolescent Psychiatry , 40(7), July 2001, pp. 762–772. doi :10.1097/00004583-200107000-00010 PMID 11437014 Kmietowicz, Zosia. "GSK backs campaign for disclosure of trial data", BMJ , 346, 7 February 2013. doi :10.1136/bmj.f819 Kondro, Wayne; Sibbald, Barbara. "Drug company experts advised staff to withhold data about SSRI use in children," Canadian Medical Association Journal , 170(5), 2 March 2004, p. 783. doi :10.1503/cmaj.1040213 PMID 14993169 Laden, Sally K.; Romankiewicz, John A. "Adolescent Depression Study 329: Proposal for a Journal Article" , Scientific Therapeutics Information, Inc, 3 April 1998. Laden, Sally K. Sally Laden to Jim McCafferty , 7 December 1998, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Laden, Sally K. Sally Laden to Jim McCafferty , 18 December 1998, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Laden, Sally K. Sally Laden–Michael Strober–Boris Birmaher correspondence , 24 August 2000, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Laden, Sally K. Sally Laden to the Paxil Team , 11 January 2001, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Laden, Sally K. Sally Laden to the Paxil Marketing Team , 25 April 2001, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Laden, Sally K. Sally Laden to Jim McCafferty , 7 August 2001, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. Deposition of Sally K. Laden , in Cheryl J. Cunningham v. SmithKline Beecham and William P. Williams v. SmithKline Beecham , United States District Court, Northern District of California, 15 March 2007.McCafferty, James P. James McCafferty to Sally Laden , 21 July 1999, courtesy of the Drug Industry Documents Archive , University of California, San Francisco. McGoey, Linsey; Jackson, Emily (February 2009). "Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity", Journal of Medical Ethics , 35(2), pp. 107–112. doi :10.1136/jme.2008.025361 PMID 19181884 JSTOR 27720271 McHenry, Leemon B. , Jureidini, Jon N. "Industry-sponsored ghostwriting in clinical trial reporting: a case study," Accountability in Research: Policies and Quality Assurance , 15(3), July–September 2008, pp. 152–167. doi :10.1080/08989620802194384 PMID 18792536 Medicines and Healthcare Products Regulatory Agency (UK). "MHRA Investigation into GlaxoSmithKline/Seroxat" , 6 March 2008.Medicines and Healthcare Products Regulatory Agency. "GSK investigation concludes" , MHRA press release, 6 March 2008. Medicines and Healthcare Products Regulatory Agency. Letter from Kent Woods, MHRA, to Jean-Pierre Garnier, GSK , 6 March 2008. Medicines and Healthcare Products Regulatory Agency. "Transcription of a meeting at MHRA about Seroxat" , MHRA meeting with patient group, 29 April 2008. Newman, Melanie. "The Rules of Retraction", BMJ , 341(7785), 11 December 2010, pp. 1246–1248. doi :10.1136/bmj.c6985 PMID 21138994 JSTOR 20800711 Pretre, Caroline. Caroline Pretre to Martin Keller , 6 February 2001.
Romankiewicz, John A. "Paxil Advisory Board Meeting , Scientific Therapeutics Information, 1 October 1993.
SmithKline Beecham. "Seroxat/Paxil Adolescent Depression: Position piece on the phase III clinical studies" , October 1998.
Westaway, Jackie. SmithKline Beachem memo , 14 October 1998.
The People of the State of New York against GlaxoSmithKline United States v. GlaxoSmithKline United States Department of Justice. "GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data" , 2 July 2012.
Letters
Weintrob, Alex. "Paroxetine in adolescent major depression" , Journal of the American Academy of Child and Adolescent Psychiatry , 41(4), April 2002, pp. 363–364.
Parsons, Mitch. "Paroxetine in adolescent major depression" , 41(4), April 2002, p. 364.
Keller, Martin; Ryan, Neal D.; Wagner, Karen Dineen. "Paroxetine in adolescent major depression" , 41(4), April 2002, p. 364.
Jureidini, Jon; Tonkin, Ann. "Paroxetine in major depression" , 42(5), May 2003 p. 514.
Keller, Martin, et al. "Paroxetine in major depression" , 42(5), May 2003, pp. 514–515.
Connor, Daniel F. "Paroxetine in major depression" , 43(2), February 2004, p. 127.
Jon Jureidini–James Shannon (GSK) correspondence , BMJ , 347, 12 November 2013.
